Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2007 Feb 1;99(3):393-8.
doi: 10.1016/j.amjcard.2006.08.042. Epub 2006 Dec 8.

Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study

Ali Ahmed  1 , Michael W Rich, Paul W Sanders, Gilbert J Perry, George L Bakris, Michael R Zile, Thomas E Love, Inmaculada B Aban, Michael G Shlipak
Affiliations
Clinical Trial

Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study

Ali Ahmed et al. Am J Cardiol. .

Abstract

Chronic kidney disease (CKD) is common and is associated with increased mortality in heart failure (HF). However, it is unknown whether the effect of CKD on mortality varies by left ventricular ejection fraction (LVEF). We evaluated the effect of CKD on mortality in patients with systolic (LVEF <or=45%) and diastolic (LVEF >45%) HF. Of the 7,788 patients in the Digitalis Investigation Group trial, 3,527 (45%) had CKD (estimated glomerular filtration rate <60 ml/min/1.73 m2). We calculated the propensity score for CKD for each patient, using a multivariate logistic regression model (c statistic 0.76, postmatch absolute standardized differences <5% for all 32 co-variates). We matched 2,399 pairs of patients with and without CKD with similar propensity scores. There were 757 (rate 1,049/10,000 person-years) and 882 (rate 1,282/10,000 person-years) deaths, respectively, in patients without and with CKD (hazard ratio 1.22, 95% confidence interval 1.09 to 1.36, p <0.0001). CKD-associated mortality was higher in those with diastolic HF (371 extra deaths/10,000 person-years, hazard ratio 1.71, 95% confidence interval 1.21 to 2.41, p = 0.002) than in systolic HF (214 extra deaths/10,000 person-years, hazard ratio 1.19, 95% confidence interval 1.07 to 1.32, p = 0.001), which was significant (adjusted p for interaction = 0.034). A graded association was found between CKD-related deaths and LVEF. The hazard ratios for CKD-associated mortality for the LVEF subgroups of <35%, 35% to 55%, and >55% were 1.15 (95% confidence interval 1.02 to 1.29), 1.35 (95% confidence interval 1.11 to 1.64), and 2.33 (95% confidence interval 1.34 to 4.06). In conclusion, CKD-associated mortality was higher in those with diastolic than systolic HF. Patients with diastolic HF should be evaluated for CKD, and the role of inhibitors of the renin-angiotensin system in these patients needs to be investigated.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None

Figures

Figure 1
Figure 1
Absolute standardized differences in baseline covariates between patients with and without chronic kidney disease, before and after propensity score matching (post-match standardized difference <5% indicate excellent covariate balance).
Figure 2
Figure 2
Kaplan-Meier plots for cumulative risk of all-cause death associated with chronic kidney disease (CKD) (SHF=systolic heart failure or heart failure with ejection fraction ≤ 45% and DHF=diastolic heart failure or heart failure with ejection fraction >45%)
Figure 3
Figure 3
Hazard ratios and 95% confidence intervals for mortality associated with chronic kidney disease (CKD) in subgroups of patients with heart failure (ACEI=angiotensin-converting enzyme inhibitor, DM=diabetes, EF=ejection fraction, NYHA=New York Heart Association)
See this image and copyright information in PMC

References

    1. Shlipak MG, Smith GL, Rathore SS, Massie BM, Krumholz HM. Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial. J Am Soc Nephrol. 2004;15:2195–2203. - PubMed
    1. Ahmed A, Kiefe CI, Allman RM, Sims RV, DeLong JF. Survival benefits of angiotensin-converting enzyme inhibitors in older heart failure patients with perceived contraindications. J Am Geriatr Soc. 2002;50:1659–1666. - PubMed
    1. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation. 2004;109:1004–1009. - PubMed
    1. Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Asso. 1984;79:516–524.
    1. Rubin DB. Using propensity score to help design observational studies: Application to the tobacco litigation. Health Services and Outcomes Research Methodology. 2001;2:169–188.

Publication types

MeSH terms